Glenmark anti-myeloma drug gets clinical trial nod from US FDA
GBR 1342 is designed to activate the patient's immune system by redirecting immune cells towards tumour tissue, which may lead to…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.